These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 36196760)

  • 21. Identification of Translocation Inhibitors Targeting the Type III Secretion System of Enteropathogenic Escherichia coli.
    Mühlen S; Zapol'skii VA; Bilitewski U; Dersch P
    Antimicrob Agents Chemother; 2021 Nov; 65(12):e0095821. PubMed ID: 34543097
    [TBL] [Abstract][Full Text] [Related]  

  • 22. EspFu-Mediated Actin Assembly Enhances Enteropathogenic
    Martins FH; Kumar A; Abe CM; Carvalho E; Nishiyama-Jr M; Xing C; Sperandio V; Elias WP
    mBio; 2020 Apr; 11(2):. PubMed ID: 32291304
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterization of the NleF effector protein from attaching and effacing bacterial pathogens.
    Echtenkamp F; Deng W; Wickham ME; Vazquez A; Puente JL; Thanabalasuriar A; Gruenheid S; Finlay BB; Hardwidge PR
    FEMS Microbiol Lett; 2008 Apr; 281(1):98-107. PubMed ID: 18279332
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The bacterial virulence factor NleA is required for the disruption of intestinal tight junctions by enteropathogenic Escherichia coli.
    Thanabalasuriar A; Koutsouris A; Weflen A; Mimee M; Hecht G; Gruenheid S
    Cell Microbiol; 2010 Jan; 12(1):31-41. PubMed ID: 19712078
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bacterial virulence factor inhibits caspase-4/11 activation in intestinal epithelial cells.
    Pallett MA; Crepin VF; Serafini N; Habibzay M; Kotik O; Sanchez-Garrido J; Di Santo JP; Shenoy AR; Berger CN; Frankel G
    Mucosal Immunol; 2017 May; 10(3):602-612. PubMed ID: 27624779
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Enteropathogenic and enterohemorrhagic Escherichia coli type III secretion effector EspV induces radical morphological changes in eukaryotic cells.
    Arbeloa A; Oates CV; Marchès O; Hartland EL; Frankel G
    Infect Immun; 2011 Mar; 79(3):1067-76. PubMed ID: 21189318
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Control of Type III Secretion System Effector/Chaperone Ratio Fosters Pathogen Adaptation to Host-Adherent Lifestyle.
    Elbaz N; Socol Y; Katsowich N; Rosenshine I
    mBio; 2019 Sep; 10(5):. PubMed ID: 31530678
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of colonization dynamics and pathology of mice infected with enteropathogenic Escherichia coli, enterohaemorrhagic E. coli and Citrobacter rodentium.
    Mundy R; Girard F; FitzGerald AJ; Frankel G
    FEMS Microbiol Lett; 2006 Dec; 265(1):126-32. PubMed ID: 17034412
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Attaching and effacing bacterial effector NleC suppresses epithelial inflammatory responses by inhibiting NF-κB and p38 mitogen-activated protein kinase activation.
    Sham HP; Shames SR; Croxen MA; Ma C; Chan JM; Khan MA; Wickham ME; Deng W; Finlay BB; Vallance BA
    Infect Immun; 2011 Sep; 79(9):3552-62. PubMed ID: 21746856
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The pathogenic E. coli type III effector EspZ interacts with host CD98 and facilitates host cell prosurvival signalling.
    Shames SR; Deng W; Guttman JA; de Hoog CL; Li Y; Hardwidge PR; Sham HP; Vallance BA; Foster LJ; Finlay BB
    Cell Microbiol; 2010 Sep; 12(9):1322-39. PubMed ID: 20374249
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Functional differences and interactions between the Escherichia coli type III secretion system effectors NleH1 and NleH2.
    Pham TH; Gao X; Tsai K; Olsen R; Wan F; Hardwidge PR
    Infect Immun; 2012 Jun; 80(6):2133-40. PubMed ID: 22451523
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Distribution of espI among clinical enterohaemorrhagic and enteropathogenic Escherichia coli isolates.
    Mundy R; Jenkins C; Yu J; Smith H; Frankel G
    J Med Microbiol; 2004 Nov; 53(Pt 11):1145-1149. PubMed ID: 15496394
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nck adaptors, besides promoting N-WASP mediated actin-nucleation activity at pedestals, influence the cellular levels of enteropathogenic Escherichia coli Tir effector.
    Nieto-Pelegrin E; Kenny B; Martinez-Quiles N
    Cell Adh Migr; 2014; 8(4):404-17. PubMed ID: 25482634
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Functional Characterization of EscK (Orf4), a Sorting Platform Component of the Enteropathogenic Escherichia coli Injectisome.
    Soto E; Espinosa N; Díaz-Guerrero M; Gaytán MO; Puente JL; González-Pedrajo B
    J Bacteriol; 2017 Jan; 199(1):. PubMed ID: 27795324
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Distinct Roles of the Antiapoptotic Effectors NleB and NleF from Enteropathogenic Escherichia coli.
    Pollock GL; Oates CVL; Giogha C; Wong Fok Lung T; Ong SY; Pearson JS; Hartland EL
    Infect Immun; 2017 Apr; 85(4):. PubMed ID: 28138023
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Regulation of nleA in Shiga toxin-producing Escherichia coli O84:H4 strain 4795/97.
    Schwidder M; Hensel M; Schmidt H
    J Bacteriol; 2011 Feb; 193(4):832-41. PubMed ID: 21131485
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tir phosphorylation and Nck/N-WASP recruitment by enteropathogenic and enterohaemorrhagic Escherichia coli during ex vivo colonization of human intestinal mucosa is different to cell culture models.
    Schüller S; Chong Y; Lewin J; Kenny B; Frankel G; Phillips AD
    Cell Microbiol; 2007 May; 9(5):1352-64. PubMed ID: 17474908
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mutagenesis and Functional Analysis of the Bacterial Arginine Glycosyltransferase Effector NleB1 from Enteropathogenic Escherichia coli.
    Wong Fok Lung T; Giogha C; Creuzburg K; Ong SY; Pollock GL; Zhang Y; Fung KY; Pearson JS; Hartland EL
    Infect Immun; 2016 May; 84(5):1346-1360. PubMed ID: 26883593
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genetic background and mobility of variants of the gene nleA in attaching and effacing Escherichia coli.
    Creuzburg K; Heeren S; Lis CM; Kranz M; Hensel M; Schmidt H
    Appl Environ Microbiol; 2011 Dec; 77(24):8705-13. PubMed ID: 22003022
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Enterohaemorrhagic Escherichia coli serogroup O111 inhibits NF-(kappa)B-dependent innate responses in a manner independent of a type III secreted OspG orthologue.
    Nobe R; Nougayrède JP; Taieb F; Bardiau M; Cassart D; Navarro-Garcia F; Mainil J; Hayashi T; Oswald E
    Microbiology (Reading); 2009 Oct; 155(Pt 10):3214-3225. PubMed ID: 19628559
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.